Fundraising FoxS32 — 2023 Investments
6 investments dated 2023 · listed companies and verified rows first · show all
Forward builds network modeling and management software that enables operators at large enterprises to understand, visualize, and troubleshoot complex network infrastructures.
Cloud ComputingCybersecurityEnterprise SoftwarePalo Alto, US
David Erickson(Founder)inNikhil Handigol(Founder)inBrandon Heller(Founder)inPeyman Kazemian(Founder)in
BoardAndreas Stavropoulos(Director)inL. William Krause(Director)
Co-investorsA.Capital VenturesAndreessen HorowitzThreshold VenturesDFJGoldman SachsOmega Venture Partners+1 more
Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides.
AI & Machine LearningBiotechMedical DevicesPalo Alto, US
Jakob Uszkoreit(Founder)inKevin Heyries(Executive Officer)inDiana Isabel Ajuria(Executive Officer)Do Soon Kim(Executive Officer)inJakob Uszkoreit Rhiju Das(Founder)Rhiju Das(Founder)
Co-investorsAndreessen HorowitzArtis VenturesObvious VenturesSection 32NVenturesNVIDIA
Puzzle builds a modern accounting system for startups and small-to-medium businesses, delivering real-time financial intelligence by reconstructing core ledger and data infrastructure.
AI & Machine LearningFintechSaaSSan Francisco, US
Sasha Orloff(Cofounder & CEO)inJohn Cwikla(Cofounder & CTO)in
BoardHEMANT TANEJA(Director)in
Co-investorsAlumni VenturesBORN CAPITAL CFOTECHFelicis VenturesFjor FoundersFOG VenturesGaingels+11 more
__Twitter.png)
Puzzle is a crypto wallet for the Aleo blockchain, available on iOS, Android, and Chrome, that includes a native Arcade offering earning opportunities to users.
Crypto & Web3Fintech
Co-investorsBain Capital CryptoFelicis VenturesGeneral CatalystKapor CapitalSterling Road
.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AltPepFunction Oncology
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.